Title:
【発明の名称】アダマンタンカルボキシイミドアミド誘導体およびNMDAアンタゴニストとしてのそれらの使用
Document Type and Number:
Japanese Patent JP2002501942
Kind Code:
A
Abstract:
The compound of the above formula wherein R1-R5 are independently selected from hydrogen, alkyl and aryl and prodrugs thereof; and pharmaceutically acceptable salts thereof; and use of the compounds in therapy, particularly for treatment of a condition generally associated with abnormalities in glutamtergic transmission.
Inventors:
Monk, Nazaniel Julius Thomas
Gillespie, Roger John
Bird, Andrew James
Gillespie, Roger John
Bird, Andrew James
Application Number:
JP2000530079A
Publication Date:
January 22, 2002
Filing Date:
February 01, 1999
Export Citation:
Assignee:
Bernaris Research Limited
International Classes:
A61K31/155; A61K31/381; A61P25/00; A61P25/14; A61P25/16; A61P25/18; A61P25/28; A61P43/00; C07C257/16; C07D333/24; (IPC1-7): C07C257/16; A61K31/155; A61K31/381; A61P25/00; A61P25/14; A61P25/16; A61P25/18; A61P25/28; A61P43/00; C07D333/24
Attorney, Agent or Firm:
Shusaku Yamamoto